X-Square Capital, LLC
- SEC CIK
- 0001729300
- Latest filing
- Aug 12, 2026
ADAPY holding history
Adaptimmune Therapeutics PLC in every 13F filed by X-Square Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADAPY overviewAll 13F holders of ADAPYFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −11,359−100.0% | Sold out | Holders |
| Q4 2025 | 11,359 | $0 | 0.0% | −214−1.8% | Reduced | Holders |
| Q3 2025 | 11,573 | $1.00K | <0.1% | +400+3.6% | Added | Holders |
| Q2 2025 | 11,173 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 11,173 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 11,173 | $6.00K | <0.1% | −7−0.1% | Reduced | Holders |
| Q3 2024 | 11,180 | $10.0K | <0.1% | −12−0.1% | Reduced | Holders |
| Q2 2024 | 11,192 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 11,192 | $14.0K | <0.1% | −16,233−59.2% | Reduced | Holders |
| Q4 2023 | 27,425 | $22.0K | <0.1% | +654+2.4% | Added | Holders |
| Q3 2023 | 26,771 | $25.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 26,771 | $25.0K | <0.1% | +26,771 | New | Holders |